WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

A new device designed to be used as a part of a programme to combat Androgenic Alopecia in clients visiting hair loss clinics or doctors’ offices has been cleared by the Food and Drug Administration in America.

Free-standing LLT device

The Freestanding Capillus272 OfficePro LLLT DeviceThe Capillus 272 OfficePro is a free-standing variation on existing Low Level Laser Therapy (LLLT) devices. It follows on from the Miami-based company’s Capillus 272 cap device, which is designed to be used at home.

According to Capillus, its OfficePro has shown ‘the capability to increase hair growth by improving circulation and cellular metabolism in and around hair follicles’ in a matter of weeks. Furthermore, for the test subjects, the level of ‘patient confidence and scalp health’ is also said to have improved over time.

This type of laser therapy is becoming increasingly popular for both men and women with genetic hair loss – more commonly known as Male Pattern Baldness or Female Pattern Hair Loss.

Many new products have been developed in this area recently, including helmet-styles like the iGrow and the Theradome which emit LLLT directly through the hair to the scalp. This works by increasing circulation and boosting cellular metabolism in the scalp, in order to boost hair growth.

However, the original, award-winning HairMax LaserComb holds an additional patent in relation to its combing technique, which allows the laser’s rays easier, more direct access to the scalp, rather than just the hair.

Although LLLT will not treat hairloss on its own, it can prove a beneficial regrowth boosting companion to clinically-proven hair loss treatment courses by helping the topical treatment minoxidil to circulate effectively.

Builds relationship between hair loss specialist and client

Clinical Therapy Treatment Can Help to Build the Relationship Between Client and Hair Loss SpecialistGiven other efficient LLLT products already exist, including ones which can be used both in-clinic and at-home by clients, what prompted the company to develop this latest medical device?

Capillus says in a press statement that offering an LLLT hair therapy product specifically for use in hair loss clinics or other treatment centres was particularly constructive as it can ‘help physicians guide men and women along their journey to a fuller head of natural hair’.

Carlos Piña, Capillus CEO, explains: “Physicians love the OfficePro because it introduces patients to laser hair therapy in the office… It is a wonderful tool for physicians to build a relationship with patients while administering treatment and monitoring results.”

Having a one-to-one session with a hair loss specialist is undeniably a valuable experience for anyone concerned about thinning hair; indeed, LLLT plays a pivotal role in some of Belgravia’s clinical therapy treatment sessions. This intimate service allows trust to build between the client and the advisor, and also allows for any issues to be addressed straight away. From advice about using treatments or hair washing, to tweaking treatment course components to ensure clients are always on the most effective and suitable courses at any given time, particularly as their lifestyle changes, it can be a huge relief for clients to have someone to talk to about their concerns.

About FDA clearance for LLLT devices

Capillus was granted a 510(k) clearance by the FDA for its 272 OfficePro model. This relates to the safety and effectiveness of new medical devices and FDA clearance must be obtained before they are introduced to the market.

The HairMax LaserComb is also FDA cleared for use by both men and women, and these are provided free of charge to Belgravia clients when they purchase annual treatment plans.

The company’s medical director, Dr. Shelly Friedman, said of the news:“The clearance substantiates what we have known and experienced clinically“. Referring to a recent independently reviewed study of the Capillus272 laser cap which reportedly found an increase of 51% in the hair counts of male and female test subjects, she added: “Capillus is very successful in converting fine, vellus hairs to normal growing hairs.”

For more information on at-home or in-clinic LLLT hair growth boosters, please contact the clinic on 020 7730 6666 or send us a message.


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


MHRA Medical License  X  |   FDA Approval  X  |   Food Supplement  X

Pharmaceutical company Cellmid Limited has produced a new hair loss product called évolis ONE which has shown promising results in an independently tested, blinded, placebo-controlled clinical study.

The spray-on product is designed to treat genetic hair loss in both men and women with minimal side effects and has various patents pending in connection with its formula.

First clinically-validated FGF5 inhibitor hair growth product

Evolis Tonics - Hair Loss ProductsAccording to reports on the B3C newswire and the évolis website, there have been ‘strong positive results in all measured areas of its independently conducted, randomized, blinded and placebo controlled human clinical study of the évolis ONE formulation’.

The product is made in Australia and took 12 years to develop. It is said to have demonstrated ‘efficacy in reducing hair loss, increasing hair growth and improving hair recovery and release’ during the trials, which were carried out by an independent CRO in New York (AMA Laboratories, INC) that specialises in dermatological product testing.

These results make Cellmid Limited, through its subsidiary Advangen Limited, the first company to introduce a clinically-validated FGF5 inhibitor hair growth product to the market in the form of its’ tonics.

The évolis tonics – one for men and one for women – are topical formulas which the website claims ‘May benefit in reducing hair loss, leading to the appearance of thicker hair’. They feature botanical extracts including poterium officinale, rosa multiflora, eriobotrya japonica, ginkgo biloba and swertia chirata.

For best results, users are advised to apply three-to-five sprays of the tonic twice daily – once in the morning then again in the evening. It should be massaged into the affected areas after shampooing, and the hair can be wet or dry during application.

The manufacturers advise users ‘will need to use évolis for a minimum of 16 weeks, twice per day every day’ in order to see results. Continued use of évolis is also recommended to maintain any results obtained, as is complimenting the tonic with shampoos from the range which also contain botanical extracts, as well as a ‘unique Catch and Release polymer to assist with volumising’.

What is FGF5?

FGF5, or ‘Fibroblast growth factor 5’ is a naturally occurring protein found in the body that is programmed by the FGF gene. It speeds up the hair growth cycle and determines hair length.

Restraining FGF5 has been found to extend the Anagen (growth) stage of the hair growth cycle in mammals, including cats and mice, producing long hair. As it also impacts the human hair cycle it is of significant interest to scientists researching hair loss treatments and cures.

The  Nishinihon Journal of Dermatology published a paper entitled ‘ “Sanguisorba Officinalis Root Extract Has FGF-5 Inhibitory Activity and Reduces Hair Loss by Causing Prolongation of the Anagen Period” in 2007. Since then many companies have tried to harness FGF5 to produce the next generation of treatments for Male Pattern Baldness and Female Hair Loss.

Whilst inhibiting FGF5 can help to prolong the hair growth phase, an excess of FGF5 has the opposite effect, leading to the hair prematurely entering the Telogen, or ‘resting’ phase, causing hair to fall out.

Results of clinical trials

Objective, independent clinical trials of évolis ONE were carried out on 32 otherwise healthy individuals, aged between 31 and 55, with androgenetic alopecia.

Men taking part measured between 2 and 4 on the Norwood scale, whilst female subjects registered I-2 to II-2 on the Ludwig scale of hair loss. The trials lasted 112 days (16 weeks) and products were applied twice daily.

Gravimetric Determination methods were used to analyse the impact of évolis ONE in reducing genetic hair loss over 112 days (16 weeks) with twice daily use. Findings showed this resulted in an 80.2% reduction in hair loss.

When testing the ‘hair differentiation’ – the ratio of growing (anagen) hairs to resting (telogen) hair follicles – results gathered based on the Van Scott “hair pluck” method found an anagen increase of 44.2% over the same period .

PhotoGrammetrix™3 measurements, a form of visual assessment using scientific photographs, used to gauge the general improvement in hair quality and volume showed an increase of 143.3%. This visual evaluation was reportedly conducted by AMA’s Institutional Review Board.

A 51 subject Repeat Insult Patch Test (RIPT) exploring skin irritation and sensitisation was also carried out by AMA Laboratories and was said to result in a “zero adverse event” report. However, évolis warns users that those ‘who suffer from a skin condition such as eczema, psoriasis or sensitive skin may experience irritation and/or a dry, itchy scalp’ and advises them to carry out a patch test first to assess their sensitivity.

Comment

Maria Halasz, CEO of Cellmid commented on the clinical trial results, saying “In addition to the hair count and hair loss measurements the photographs taken during the PhotoGrammetrix™ evaluation demonstrate visible improvement in overall hair quality and volume… As this product has active ingredients subject to Cellmid’s recently filed patent application, the results give us multiple opportunities to commercialise this valuable asset.

Darren Jones, Head of Product Development at Cellmid, added, “These are very exciting and valuable results expected to support stronger clinical hair growth claims of this proprietary product. FGF5 is well recognised as the ultimate controller of hair loss. We are excited to be the first on the market with a clinically validated product range addressing FGF5” he added.

Leonora Doclis, Senior Trichologist at The Belgravia Centre said, “The exploration of FGF5 inhibitors is an innovative approach to developing new hair loss treatments and the results of évolis’ in vitro tests suggest this could be an exciting area to explore. However, as these tests were carried out on a fairly small scale, it would be interesting to see wider-ranging research carried out into the efficacy of these tonics used both on their own and in conjunction with other existing hair loss treatments like minoxidil. As the évolis formula comprises four botanical ingredients it may prove a good, natural hair growth booster to use alongside medically-proven hair loss treatments”.

Ingredients

évolis tonic for Men: Purified water, ethanol, butylene glycol, ginkgo biloba extract, eriobotrya japonica leaf extract, panthenyl ethyl ether, swertia chirata extract, glycyrrhetinic acid, citric acid, sodium citrate, maltodextrin

évolis tonic for Women: Purified water, ethanol, butylene glycol, poterium officinale root extract, rosa multiflora fruit extract, panthenyl ethyl ether, swertia chirata extract, glycyrrhetinic acid, citric acid, sodium citrate, maltodextrin

Information correct at date of publishing: May 2015

MHRA Medical License  X  |   FDA Approval  X  |   Food Supplement  X

Mibelle Biochemistry believes a basil extract may hold the key to combating genetic hair loss. The Basilicum extract features in the company’s newly launched RootBioTec HO product which is a cosmetic formula designed to be used in hair oils, serums and conditioners as well as in anti-ageing haircare products.

This new basil extract ‘cosmetic active’ product is said to stimulate hair papilla cells and reduce hair loss. The company also claims RootBioTech HO gives ‘fuller hair’ and ‘rejuvenates [the] scalp’.

Speaking to Cosmetics Design Europe, the Head of Research for Mibelle Biochemistry, Dr. Daniel Schmid, explained, “It strongly inhibits the activity of 5 alpha reductase II – the enzyme that promotes the conversion of testosterone to DHT, ultimately stimulating demal papilla cells and helps renew hair activity in those that suffer from androgenic alopecia“.

Androgenic alopecia – more commonly known as Male Pattern Baldness or Female Pattern Hair Loss – occurs when people have an hereditary sensitivity to dihydrotestosterone (‘DHT’) – the hormone that causes this type of hair loss.

If left untreated, DHT will bind to the hair follicles around the top of the head in those with a genetic predisposition, weakening them until the hair gradually thins and sheds. RootBioTec HO is hoping to address this by preventing the formation of DHT, reducing hair loss boosting regrowth.

Product claims and study findings

Studies into this new hair loss product were carried out by its manufacturer, Mibelle Biochemistry. Details of the study findings are as follows:

Reducing hair loss:

Mibelle Biotech Chart showing Anti-Hair Loss Effect of RootBioTec HO

Mibelle Biotech Chart showing Anti-Hair Loss Effect of RootBioTec HO

According to the company’s marketing information, ‘The effect of RootBioTec HO against hair loss was evaluated on 19 women and 2 men aged between 25 and 67 years (average 51.1 years) suffering from mild to moderate hair loss (daily hair loss >100 strains)’.

This clinical trial lasted two months and required each of the volunteers to apply a fluid containing one per cent RootBioTec HO directly to their scalps, once every evening.

Results were measured at the end of month one and the end of month two. This was done by asking the volunteers to collect the hair they lost from combing every morning, then counting it. The study notes that ‘For the analysis the average was taken from total counts made on three consecutive days’.

The findings showed that the number of lost hairs dropped by 26 per cent after one month and reduced by 31 per cent after two months of using RootBioTec HO. On this basis the manufacturer claims its product ‘significantly reduces hair loss and thus leads to denser hair’.

Mibelle Biotech Graph showing Concentration of Basilicum Extract

Mibelle Biotech Graph Showing Concentration of Basilicum Extract Against Inhibition of 5a Reductase

Inhibiting DHT:

In order to investigate whether RootBioTec Basilicum extract could be a potent 5α reductase inhibitor, Mibelle states that it ‘was measured and compared to Finasteride’.

Details of how this was tested or who the product was tested on are not contained within the report, however, it is unlikely to be the same group of volunteers from the above mentioned study as finasteride 1mg is a male hair loss treatment and only two men were surveyed previously.

Mibelle says the results showed ‘a clear concentration dependent inhibition of 5α reductase II activity with an IC 50 value of 2.62 mg/ml. Consequently, RootBioTec HO might be able to reduce hair loss in people with androgenic alopecia’.

Hair growth boosting effects:

RootBio Tec’s literature talks about the dermal papilla cells ‘located within the hair follicle bulb’, advising that they are essential for hair growth.

Mibelle Biochemistry Diagram Explaining how RootBioTec HO Can Contribute to Increased Proliferation of Dermal Papilla Cells

Mibelle Biochemistry Diagram Explaining how RootBioTec HO Can Contribute to Increased Proliferation of Dermal Papilla Cells

It goes on to explain how multiplication of these dermal papilla cells was investigated, stating: ‘The effect of RootBioTec Basilicum extract on dermal papilla cell proliferation was investigated by the MTT assay.

Human dermal papilla cells were serum starved for 18 hours to stop cell proliferation and then treated with RootBioTec Basilicum extract during a period of 72 hours.’

Further noting that a positive control of cell proliferation of VEGF (vascular endothelial growth factor) was employed.

Providing a chart – pictured – showing the results, the information states that these showed that ‘RootBioTec HO can stimulate the dermal papilla cells to regain their proliferation capacity’.

Mibelle Biochemistry Chart comparing RootBioTec Basilicum extract to Finasteride

Mibelle Biochemistry Chart Comparing RootBioTec Basilicum Extract to Finasteride

Comment

Whilst RootBioTec HO certainly sounds like a positive addition to currently hair loss product offerings, the scale of the studies mentioned by the company is very small. In order to properly determine the product’s efficacy, we would like to see more research done on a larger scale, with clinical trials into all claims across an equal mix of men and women with similar levels of hair loss.

The fact that RootBioTec HO is listed as a cosmetic active means it would not be eligible for MHRA or FDA licensing given these regulators operate within the medical sector.

Current statistics show how effective their product is at boosting hair growth by comparing it to finasteride – a medication that is designed to inhibit DHT and treat male pattern hair loss when taken in 1mg doses. A more useful comparison would perhaps have been between RootBioTec and Minoxidil, a hair loss treatment for both men and women with hereditary hair loss, which is licensed by the MHRA and FDA for this purpose.

From the lists of ingredients, there is nothing included that has been proven to inhibit hereditary hair loss. Overall, RootBioTec HO seems to operate in a similar way to Azelaic Acid, a licensed medication which is added to some minoxidil formulations in order to boost the efficacy of this topical hair loss treatment.

RootBioTec ingredients

RootBioTec HO (Oil-based version): Ocimum Basilicum Hairy Root Culture Extract (and) Helianthus Annuus (Sunflower) Seed Oil (and) Cocos Nucifera (Coconut) Oil

RootBioTec HW (water-based version): Ocimum Basilicum Hairy Root Culture Extract (and) Alcohol (and) Aqua/Water

Related Stories


Rogaine (known as ‘Regaine’ in the UK) has recently launched a new once-a-day foam treatment for female pattern hair loss with 5% minoxidil, in the United States. The new product has been introduced in addition to Rogaine’s existing product for women, which is a twice-per-day solution containing 2% Minoxidil.

Women's Rogaine Once Per Day FoamIs Minoxidil foam effective for treating hair loss?

According to reports from the manufacturer, clinical data showed that use of the product for 24 weeks results resulted in ‘some’ hair regrowth for 81% of the women who took part in the trial. However, it is not known what level of regrowth was achieved by these users or the stage of their hair loss when they started these trials.

Although the foam format of the product is designed to make it ‘fit into the regular beauty routine’ of the user, the evidence suggests this is probably less effective than a liquid product of the same strength. An ongoing Belgravia survey has discovered that men who have used the 5% liquid Regaine reported better results than those who have used Regaine 5% foam.

The reason for this may be to do with how effectively a foam is able to reach the scalp and soak into the skin. In order for a foam product to work as intended, it needs to be applied directly to the scalp to enable it to penetrate the skin. The directions for the Regaine foam products do instruct the user to massage it into the scalp, but it’s likely the hairloss product would also be absorbed into the hair by applying it in this way, meaning less of the foam gets to the affected areas.

Minoxidil as a hair loss treatment for women

Minoxidil is the only medically-proven treatment for genetic hair loss in women. It is medically licensed by the MHRA in the UK and approved by the equivalent body, the FDA in the USA.

Minoxidil encourages hair growth by reactivating dormant hair follicles. When applied to the scalp and absorbed into the scalp, minoxidil is converted into ‘minoxidil sulphite’, which is thought to activate potassium channels in cells, stimulating growth.

Whilst minoxidil has been seen to successfully reduce hereditary hairloss and boost hair growth for many, the degree of success will depend on the specific individual’s stage of thinning and the duration of their condition before seeking professional assistance. If you are concerned about thinning hair or female pattern hair loss it is best to seek expert advice as soon as possible.Female Pattern Hair Loss Patient Before and After Photos

Belgravia’s custom approach

Belgravia’s hair loss experts recommend customised, comprehensive women’s hair loss treatment programmes featuring recommended minoxidil formulations and boosters, based on their diagnosis of your condition. These bespoke treatment plans are designed specifically for each client and our patients – as well as many of their friends and families – are often amazed at the results they experience. You can find out more about the range of high strength minoxidil products available from Belgravia’s in-clinic pharmacies by calling us on 020 7730 6666.

There are many examples in our photographic Hair Loss Success Stories of clients who have used our treatments to fight female hair loss. These include Diane, pictured here, who said of her treatment, “Very happy and I can see results within the first year“. Click on the photos to view her Success Story in full.


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


New products designed to conceal hair loss are always being released, but the latest ‘KeraFiber’ powder promises to thicken the appearance of your hair instantly. Is this new craze just a flash in the pan, or does it provide real results for men and women affected by hair loss?

Kerafiber keratin hair fibre hair loss concealer product

Hair loss concealers such as KeraFiber mask, rather than treat, thinning hair

With eight million UK women with hair loss and a quarter of men affected by thinning hair by the time they are in their 30s, a product designed to conceal hair loss is sure to be in demand. KeraFiber is made from keratin, a protein naturally found in our skin, hair and nails. Statically charged fibres work by bonding to the user’s natural hair, for a secure hold. This thickens the appearance of the hair and can be set by using hairspray. The product is already proving popular with celebrity hair and make-up artists in the US and is now available in the UK.

Fibre hair loss concealers: nothing new

Fibre hair loss concealers are nothing new – Toppic and Couvre came out 30 years ago, and Nanogen previously released their ‘Nanofibres‘ product, which also uses microscopic keratin fibres to artificially add thickness and volume to hair. The fibres come in a pepper pot-style shaker which is applied to the scalp for a supposedly natural looking effect.

It is worth noting that keratin fibre concealers can only be used if you have some hair remaining on your scalp. They are not suitable for anyone who is completely bald and, if the underlying cause of your hair loss is not treated (as opposed to masked) your hair may continue to shed until these concealers no longer work.

Masking symptoms versus treating the cause

These keratin fibre concealers may be a ‘quick fix’ option for anyone looking to conceal hair loss or thinning hair, but remember they simply mask symptoms rather than treating the root cause of hair loss.

The average person sheds around 100 hairs a day, but if you have started to notice more hairs than usual in your brush or on your pillow, it’s time to see a professional hair loss expert who can diagnose the cause and prescribe a personalised hair loss treatment plan, if appropriate.

There are many different hair loss conditions, from genetic baldness, through to autoimmune conditions such as Alopecia, or lifestyle-related hair loss – many of which can be treated. The best treatment plan will vary according to what kind of hair loss you have and how advanced it is.


Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related stories:

Most Effective Treatments for Female Hair Loss How to Style Thinning Hair Whilst You Grow it Back Hair Loss Treatments for Men
FIND OUT ABOUT: Hair Loss Treatments for Women How to Style Thinning Hair Whilst You Grow It Back FIND OUT ABOUT: Hair Loss Treatments for Men

An American company claims its new Theradome laser helmet is the first wearable laser scalp treatment to “stop hair loss, thicken existing hair and grow new hair”, but can this helmet really cure baldness?

Designed by a former NASA scientist, to be worn twice per week for 20 minutes at a time, the headgear is marketed more towards women with hair loss issues as, currently, the Theradome has only been FDA-cleared for use by women with their FDA clearance for men still pending

The cordless hair restoration device uses 80 cooling lasers that provide over 560 mW of low level laser therapy. This is meant to grow new, healthy hair whilst doubling the hair follicle size of existing hair, in addition to slowing down or stopping hair loss, with no side effects. Can this helmet cure baldness?

Theradome claims to show results over a period of over 100 weeks. After 18-24 weeks Theradome advises your hair will be ‘cleaner, more manageable…with improved lustre and fuller body’, with thicker, longer hair and a healthier scalp occurring after 26-50 weeks of continued use of the helmet. From 52 weeks they say you will start to see ‘the hairs on the top of the head and the vertex will start filling in’, then from the 100 week treatment mark onwards, Theradome claims users will experience ‘fuller and thicker hair will result with continued use’.

Two clinical trials were conducted by Theradome and their results state that the hair loss helmet was proven to regrow hair in 98% of users. Additionally, the studies found that hair thickness, volume and density increased by 200% within six weeks.

Our highly respected hair transplant partner, Dr Bessam Farjo, told the Daily Mail: ‘I do believe that laser technology has validity, but I’m sceptical of the specific claims made by Theradome GB that this particular headgear has the ability to increase the hair shaft diameter by 200 per cent. I have not seen any scientific evidence to support this.

‘It’s great to see businesses putting resources to the development of this technology, but more scientific results are needed to back-up the huge claims that Theradome is making.’

From the information available, this helmet appears to be potentially more of a hair growth booster rather than a hair loss treatment. Whilst hair growth boosters are an integral part of any full hair loss treatment programme, for optimum results they should be used alongside specialist medications developed to stop hair loss and start the regrowth process.

Theradome advises its helmet can be used alongside other hair loss treatments, stating that by doing so ‘your hair recovery will be even more rapid than just taking the pills alone.’

The laser therapy operates  in a similar way to the convenient HairMax LaserComb which, unlike the Theradome, is FDA-cleared for use by both men and women. A complimentary HairMax LaserComb can be included within most of Belgravia’s treatment courses.

These types of Hair Growth Boosters work primarily by stimulating the scalp to increase blood flow to the area, reducing inflammation of the scalp which can also help with scalp conditions such as dermatitis. This stimulus encourages hair growth, allowing the regrowth medication (usually Minoxidil) to work more effectively, whilst maintaining the condition of the hair and scalp.

If you would like our hair loss specialists to provide personal advice on the best course of treatment for your condition, call us on 020 7730 6666 or send us a message to book your free consultation. If you are unable to get to either of our Central London hair loss clinics, just complete our Online Diagnostic Form.

For information on the bespoke minoxidil products available from The Belgravia Centre please contact us by calling 020 7730 6666 or arrange a free consultation.

Below we have provided a selection of Belgravia’s hair loss success stories. Click on an image for the full success story, or view our full gallery of hair loss success stories.

Receding Hairline

Receding Hairline

Receding Hairline

Receding Hairline

 

Male Pattern Hair Loss Photoscans The Belgravia Centre“I thought doing one of these things would never work but to my surprise after 3 months it began to work!  I saw a big improvement in the crown area and it just kept improving after that, I really would recommend this to anyone who is a bit sceptical about these things, it doesn’t promise to make miracles but if you want a major difference in your hair loss – use these guys!”

Cass

Diagnosis:  Male Pattern Hair Loss 

Male Pattern Hair Loss Comment The Belgravia Centre

Regaine Foam

The active ingredient found in Regaine foam (known in the US as ‘Rogaine’) is minoxidil (5%), which is the same active ingredient and dose, as Regaine’s classic Regaine 5% minoxidil liquid. The only difference between the two, which is also the selling point, is that the form of the new product is a foam or ‘mousse’ as opposed to a liquid. The TV advert features a man spraying some foam on his hand and applying it to an area of thin hair on his crown.

Our initial thoughts about the product are that it won’t in fact be as effective as a liquid minoxidil formulation. If applied correctly, a liquid can be placed directly on the scalp and optimally absorbed. Even if some of the liquid lands on the hair, the laws of gravity will ensure most will drip onto the scalp as required.

With a foam, however, it will be very difficult (almost impossible, in fact) for all of the product to be applied to the scalp and we would imagine the majority would be absorbed by the hair, depending of course on the thickness of the user’s hair. If you observe the TV advert for Regaine Foam, you will notice that when the user applies the foam, none actually seems to reach his scalp, but instead gets absorbed by his hair. Absorption into the hair would be of no use to somebody wishing to prevent thinning hair, as it is required that the product penetrates the scalp in order to reach hair follicles.

An ongoing survey carried out by The Belgravia Centre has found that people who have used Regaine 5% liquid have in fact reported better results than those who have used Regaine 5% Foam. This is likely because of the texture and method of application, as mentioned above.

There are a number of high strength minoxidil formulations available from The Belgravia Centre. To find out more, please contact the clinic.